754 related articles for article (PubMed ID: 34620056)
1. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
2. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
4. Overview of the Importance of Biotics in Gut Barrier Integrity.
Kocot AM; Jarocka-Cyrta E; Drabińska N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
Peterson CT
J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
[TBL] [Abstract][Full Text] [Related]
7. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
8. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
Cho MS; Kim SY; Suk KT; Kim BY
J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
Dahiya D; Nigam PS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.
Satokari R
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443276
[TBL] [Abstract][Full Text] [Related]
11. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
Ullah H; Tovchiga O; Daglia M; Khan H
Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
[TBL] [Abstract][Full Text] [Related]
12. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
13. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
Baldi S; Mundula T; Nannini G; Amedei A
World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
[TBL] [Abstract][Full Text] [Related]
15. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
Panebianco C; Andriulli A; Pazienza V
Microbiome; 2018 May; 6(1):92. PubMed ID: 29789015
[TBL] [Abstract][Full Text] [Related]
16. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
[TBL] [Abstract][Full Text] [Related]
17. Neonatal Microbiome: Is it Still Beneficial?
Elfarargy MS; Elbadry DH; Ahmad AR; Elhady HA
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):617-625. PubMed ID: 37916638
[TBL] [Abstract][Full Text] [Related]
18. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
[TBL] [Abstract][Full Text] [Related]
19. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
Chou YT; Kan WC; Shiao CC
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]